As shown in Figure 5(b), combining Wortmannin and rapamycin to inhibit PI3K and mTOR did not significantly enhance IL-12p70 secretion by DC-tumor hybrid cells, hence excluding a synergistic or additive effect of these inhibitors. This evidence concerns the gene MTOR and neoplasm.